Key facts
- This page summarizes Lawrence Bernard Gozlan's Form 4 filing for ALTERITY THERAPEUTICS LTD (ATHE).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 23 Jun 2026, 19:38.
Lawrence Bernard Gozlan - 15 Jun 2026 Form 4 Insider Report for ALTERITY THERAPEUTICS LTD (ATHE)
- Reporting relationship
- Director
- Issuer ticker
- ATHE
- Reported as of
- 15 Jun 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 23 Jun 2026, 19:38:00 UTC
- Prior SEC filing
- 10 Apr 2026
- Source filing
- View source filing
- Reporting owner signature
- Lawrence Bernard Gozlan
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Lawrence Bernard Gozlan filed Form 4 for ALTERITY THERAPEUTICS LTD (ATHE) on 23 Jun 2026.
Change
- Previous filing in this sequence was filed on 10 Apr 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0002127737
Primary reporting owner
Gozlan Lawrence Bernard
- Relationship
- Director
- Address
- LEVEL 15, 500 COLLINS STREET, MELBOURNE, AUSTRALIA
- Signature
- Lawrence Bernard Gozlan
- Signature date
- 23 Jun 2026
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ATHE
transaction
Derivative
Listed option exp 15 Jun 2031
Award
- Transaction value
- Shares
- +1,000,000
- Change %
- Price
- $0.000000*
- Shares after
- 1,000,000
- Date
- 15 Jun 2026
- Ownership
- Montoya Pty Ltd <Buttercup A/C>
- Underlying class
- Ordinary shares
- Underlying amount
- 1,000,000
- Exercise price
- $1.00
* marks a reported price that did not pass the local price check.